Ogivri 150 mg powder for concentrate for solution for infusion

Company:
Gerard Laboratories
Status:
No Recent Update
Active Ingredients * :
Trastuzumab
This medicinal product is subject to additional monitoring.
*Additional information is available upon request
Legal Category:
Product subject to restricted prescription (C)

What is a Patient Information leaflet and why is it useful?
A Patient Information Leaflet (PIL) is the leaflet containing information on taking or using a medicine for patients, included with medicine packaging. It is written by pharmaceutical companies as a patient version of the Summary of Product Characteristics (SPC). Changes to the PIL after your medicine was packed may mean the version on medicines.ie may differ from the version found with your medicine.

Product Information *